Literature DB >> 18770863

Transcriptional profiling identifies an interferon-associated host immune response in invasive squamous cell carcinoma of the skin.

Joerg Wenzel1, Stefan Tomiuk, Sabine Zahn, Daniel Küsters, Anja Vahsen, Andreas Wiechert, Sandra Mikus, Michael Birth, Marina Scheler, Dagmar von Bubnoff, Jens M Baron, Hans F Merk, Cornelia Mauch, Thomas Krieg, Thomas Bieber, Andreas Bosio, Kay Hofmann, Thomas Tüting, Bettina Peters.   

Abstract

Squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) represent the 2 most common types of nonmelanoma skin cancer. Both derive from keratinocytes but show a distinct biological behavior. Here we present transcriptional profiling data of a large cohort of tumor patients (SCC, n = 42; BCC, n = 114). Differentially expressed genes reflect known features of SCC and BCC including the typical cytokeratin pattern as well as upregulation of characteristic cell proliferation genes. Additionally, we found increased expression of interferon (IFN)-regulated genes (including IFI27, IFI30, Mx1, IRF1 and CXCL9) in SCC, and to a lower extent in BCC. The expression of IFN-regulated genes correlated with the extent of the lesional immune-cell infiltrate. Immunohistological examinations confirmed the expression of IFN-regulated genes in association with a CXCR3+ cytotoxic inflammatory infiltrate on the protein level. Of note, a small subset of SCC samples with low expression of IFN-regulated genes included most organ transplant recipients receiving immunosuppressive medication. Collectively, our findings support the concept that IFN-associated host responses play an important role in tumor immunosurveillance in the skin. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18770863     DOI: 10.1002/ijc.23799

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

1.  CXCR3 enhances a T-cell-dependent epidermal proliferative response and promotes skin tumorigenesis.

Authors:  Ashley E Winkler; Joshua J Brotman; Meredith E Pittman; Nancy P Judd; James S Lewis; Robert D Schreiber; Ravindra Uppaluri
Journal:  Cancer Res       Date:  2011-07-06       Impact factor: 12.701

2.  Transcriptomic analyses of genes differentially expressed by high-risk and low-risk human papilloma virus E6 oncoproteins.

Authors:  Pooja Ganguly; Niladri Ganguly
Journal:  Virusdisease       Date:  2015-06-26

3.  Osteosarcoma is characterised by reduced expression of markers of osteoclastogenesis and antigen presentation compared with normal bone.

Authors:  L Endo-Munoz; A Cumming; S Sommerville; I Dickinson; N A Saunders
Journal:  Br J Cancer       Date:  2010-06-15       Impact factor: 7.640

Review 4.  Opposing Roles of Type I Interferons in Cancer Immunity.

Authors:  Giselle M Boukhaled; Shane Harding; David G Brooks
Journal:  Annu Rev Pathol       Date:  2020-12-02       Impact factor: 23.472

5.  An attempt at a molecular prediction of metastasis in patients with primary cutaneous melanoma.

Authors:  Melanie Gschaider; Friederike Neumann; Bettina Peters; Florian Lenz; Michael Cibena; Malgorzata Goiser; Ingrid Wolf; Jörg Wenzel; Cornelia Mauch; Wolfgang Schreiner; Stephan N Wagner
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

6.  C/EBPδ gene targets in human keratinocytes.

Authors:  Serena Borrelli; Daniele Fanoni; Diletta Dolfini; Daniela Alotto; Maria Ravo; Olì Maria Victoria Grober; Alessandro Weisz; Carlotta Castagnoli; Emilio Berti; M Alessandra Vigano; Roberto Mantovani
Journal:  PLoS One       Date:  2010-11-02       Impact factor: 3.240

Review 7.  An immunologic portrait of cancer.

Authors:  Maria Libera Ascierto; Valeria De Giorgi; Qiuzhen Liu; Davide Bedognetti; Tara L Spivey; Daniela Murtas; Lorenzo Uccellini; Ben D Ayotte; David F Stroncek; Lotfi Chouchane; Masoud H Manjili; Ena Wang; Francesco M Marincola
Journal:  J Transl Med       Date:  2011-08-29       Impact factor: 5.531

8.  Interferon-β signaling contributes to Ras transformation.

Authors:  Yu-Chen Tsai; Sidney Pestka; Lu-Hai Wang; Loren W Runnels; Shan Wan; Yi Lisa Lyu; Leroy F Liu
Journal:  PLoS One       Date:  2011-08-29       Impact factor: 3.240

9.  A novel in silico reverse-transcriptomics-based identification and blood-based validation of a panel of sub-type specific biomarkers in lung cancer.

Authors:  Debmalya Barh; Neha Jain; Sandeep Tiwari; John K Field; Elena Padin-Iruegas; Alvaro Ruibal; Rafael López; Michel Herranz; Antaripa Bhattacharya; Lucky Juneja; Cedric Viero; Artur Silva; Anderson Miyoshi; Anil Kumar; Kenneth Blum; Vasco Azevedo; Preetam Ghosh; Triantafillos Liloglou
Journal:  BMC Genomics       Date:  2013-10-25       Impact factor: 3.969

10.  Absence of gamma-interferon-inducible lysosomal thiol reductase (GILT) is associated with poor disease-free survival in breast cancer patients.

Authors:  Yu-Juan Xiang; Ming-Ming Guo; Cheng-Jun Zhou; Lu Liu; Bo Han; Ling-Yu Kong; Zhong-Cheng Gao; Zhong-Bing Ma; Lu Wang; Man Feng; Hai-Ying Chen; Guo-Tao Jia; De-Zong Gao; Qiang Zhang; Liang Li; Yu-Yang Li; Zhi-Gang Yu
Journal:  PLoS One       Date:  2014-10-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.